Fortitude Q2 revenue $20.9M, adj EBITDA $8.5M; buys 9.4% HSCS stake ahead of merger

HeartSciences Inc.

Fortitude Q2 2026 revenue $20.9M; adjusted EBITDA $8.5M.
Mined ~33,646 ZEC at 4.0 GSol/s avg hash rate; 60+ MW across 7 sites.
On Aug 12, 2026 Fortitude bought 411,522 HSCS shares at $2.43 VWAP (22% premium), now owns ~9.4%.
Proposed merger with HeartSciences expected to close H2 2026; exchange ratio unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.